Section Arrow
Quote
GENB.NASDAQ
- Generate Biomedicines, Inc.
Quotes are at least 15-min delayed:2026/11/04 16:54 EST
After Hours
Last
 14.28
+0.12 (+0.85%)
Bid
13.88
Ask
14.35
High 14.35 
Low 13.88 
Volume 8.17K 
Regular Hours (Closed)
Last
 14.16
+0.31 (+2.24%)
Day High 
14.34 
Prev. Close
13.85 
1-M High
16.46 
Volume 
636.27K 
Bid
13.88
Ask
14.35
Day Low
13.4 
Open
14.27 
1-M Low
11.84 
Market Cap 
1.78B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 13.65 
20-SMA 13.38 
50-SMA 14.86 
52-W High 22.6699 
52-W Low 11 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.09/-2.09
Enterprise Value
1.83B
Balance Sheet
Book Value Per Share
3.55
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
31.89M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CRISCuris Inc.1.11+0.3961+55.48%0.2PE
After Hours 1.09 -0.02 -1.80%
KPTIKaryopharm Therapeutics Inc.0.0729-0.0154-17.44%-- 
After Hours 0.0762 +0.0033 +4.53%
GERNGeron Corp1.08+0.15+16.13%-- 
After Hours 1.07 -0.01 -0.93%
INOInovio Pharmaceuticals1.62-0.04-2.41%-- 
After Hours 1.61 -0.01 -0.62%
RXRXRecursion Pharmaceuticals3.88+0.2+5.43%-- 
After Hours 3.8784 -0.0016 -0.04%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology byusing machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.